Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 22, 2023
Aggregation of Disrupted in Schizophrenia 1 arises from a central region of the protein
Beti Zaharija, Nicholas J Bradshaw
Methods in Molecular Biology (Clifton, N.J.)
|
October 31, 2022
Mapping the Domain Structure and Aggregation Propensity of Proteins Using a Gateway Plasmid Vector System
Beti Zaharija, Nicholas J Bradshaw
Molecular Psychiatry
|
August 10, 2018
Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness
Nicholas J Bradshaw, Carsten Korth
Neuropharmacology
|
January 4, 2011
DISC1-binding proteins in neural development, signalling and schizophrenia
Nicholas J Bradshaw, David J Porteous
Molecules (Basel, Switzerland)
|
October 30, 2020
The TRIOBP Isoforms and Their Distinct Roles in Actin Stabilization, Deafness, Mental Illness, and Cancer
Beti Zaharija, Bobana Samardžija, Nicholas J Bradshaw
Cellular and Molecular Life Sciences : CMLS
|
October 16, 2016
NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness
Nicholas J Bradshaw, Mirian A F Hayashi
Biomolecular Concepts
|
October 5, 2013
NDE1 and NDEL1: twin neurodevelopmental proteins with similar 'nature' but different 'nurture'
Nicholas J Bradshaw, William Hennah, Dinesh C Soares
Scientific Reports
|
February 11, 2026
Levels of aggregation of proteins related to mental illness, assayed by insolubility, vary across the brains of individuals
Bobana Samardžija, Éva Renner, Miklós Palkovits, et al.
Biophysical Chemistry
|
February 21, 2024
Amyloids, amorphous aggregates and assemblies of peptides - Assessing aggregation
Maja Juković, Ivana Ratkaj, Daniela Kalafatovic, et al.
Psychiatria Danubina
|
July 22, 2023
SYMPTOM SEVERITY IN SCHIZOPHRENIA PATIENTS WITH NPAS3, DYSBINDIN-1 AND/OR TRIOBP PROTEIN PATHOLOGY IN THEIR BLOOD SERUM: A PANSS-BASED FOLLOW UP STUDY
Aristea Pavešić Radonja, Sandra Blažević Zelić, Gordana Rubeša, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 22, 2023
Aggregation of Disrupted in Schizophrenia 1 arises from a central region of the protein
Beti Zaharija, Nicholas J Bradshaw
Methods in Molecular Biology (Clifton, N.J.)
|
October 31, 2022
Mapping the Domain Structure and Aggregation Propensity of Proteins Using a Gateway Plasmid Vector System
Beti Zaharija, Nicholas J Bradshaw
Molecular Psychiatry
|
August 10, 2018
Protein misassembly and aggregation as potential convergence points for non-genetic causes of chronic mental illness
Nicholas J Bradshaw, Carsten Korth
Neuropharmacology
|
January 4, 2011
DISC1-binding proteins in neural development, signalling and schizophrenia
Nicholas J Bradshaw, David J Porteous
Molecules (Basel, Switzerland)
|
October 30, 2020
The TRIOBP Isoforms and Their Distinct Roles in Actin Stabilization, Deafness, Mental Illness, and Cancer
Beti Zaharija, Bobana Samardžija, Nicholas J Bradshaw
Cellular and Molecular Life Sciences : CMLS
|
October 16, 2016
NDE1 and NDEL1 from genes to (mal)functions: parallel but distinct roles impacting on neurodevelopmental disorders and psychiatric illness
Nicholas J Bradshaw, Mirian A F Hayashi
Biomolecular Concepts
|
October 5, 2013
NDE1 and NDEL1: twin neurodevelopmental proteins with similar 'nature' but different 'nurture'
Nicholas J Bradshaw, William Hennah, Dinesh C Soares
Scientific Reports
|
February 11, 2026
Levels of aggregation of proteins related to mental illness, assayed by insolubility, vary across the brains of individuals
Bobana Samardžija, Éva Renner, Miklós Palkovits, et al.
Biophysical Chemistry
|
February 21, 2024
Amyloids, amorphous aggregates and assemblies of peptides - Assessing aggregation
Maja Juković, Ivana Ratkaj, Daniela Kalafatovic, et al.
Psychiatria Danubina
|
July 22, 2023
SYMPTOM SEVERITY IN SCHIZOPHRENIA PATIENTS WITH NPAS3, DYSBINDIN-1 AND/OR TRIOBP PROTEIN PATHOLOGY IN THEIR BLOOD SERUM: A PANSS-BASED FOLLOW UP STUDY
Aristea Pavešić Radonja, Sandra Blažević Zelić, Gordana Rubeša, et al.
Page
of 4